Alkermes ALKS License — Revenue
Discontinued — last reported Q1 '22
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Alkermes in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Alkermes’s 10-Q, filed April 26, 2023, on SEC EDGAR. View the filing →
Ask your AI about Alkermes's license — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alkermes's license — revenue?
- Alkermes (ALKS) reported license — revenue of $2M in Q1 2022.
- What does license — revenue mean?
- Revenue earned by the company from granting other businesses the right to use its intellectual property or technology.
- How do you interpret license — revenue?
- An increase indicates growing demand for the company's proprietary technology or successful monetization of its intellectual property portfolio. A decrease may signal the expiration of key licenses, reduced market interest in the company's technology, or a shift in strategic focus away from licensing arrangements.
- How does license — revenue compare across companies?
- Peers in the biotechnology and pharmaceutical sectors often report this as 'Licensing Revenue' or 'Royalty and Milestone Revenue,' which can be highly variable depending on the timing of contract renewals and clinical development milestones.